Literature DB >> 10971509

Distribution of age-related thymulin titres in normal subjects through the course of life.

R Consolini1, A Legitimo, A Calleri, M Milani.   

Abstract

The thymus has a dominant immunological role in utero and in early childhood, being a primary source of T lymphopoiesis, and its investigation may be particularly relevant for the immunological study of paediatric patients. Thymulin, a nonapeptide secreted by the thymus, is an essential hormone for T lymphocyte differentiation and function. As thymulin values in the normal population have not been well documented, especially for children under the age of 1 year, we detail thymic endocrine function by presenting age-related plasma thymulin levels in a large series (n = 93) of healthy individuals, ranging from birth to old age. We demonstrate that thymulin is already detectable at birth; it then gradually increases with age, reaching the highest level in children aged 5-10 years. Starting at adolescence, thymulin titres gradually start to fall, reaching the lowest value at 36 years of age and remaining steady until 80 years (the oldest person tested).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971509      PMCID: PMC1905732          DOI: 10.1046/j.1365-2249.2000.01315.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  A new radioimmunoassay for the thymic peptide thymulin, and its application for measuring thymulin in blood samples.

Authors:  B Safieh; M D Kendall; J C Norman; E Metreau; M Dardenne; J F Bach; J M Pleau
Journal:  J Immunol Methods       Date:  1990-03-09       Impact factor: 2.303

2.  Circulating thymic hormone activity in young cancer patients.

Authors:  R Consolini; B Cei; P Cini; E Bottone; L Casarosa
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

3.  Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases.

Authors:  T Iwata; G S Incefy; S Cunningham-Rundles; C Cunningham-Rundles; E Smithwick; N Geller; R O'Reilly; R A Good
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

4.  Endocrine control of thymic serum factor production in young-adult and old mice.

Authors:  N Fabris; E Mocchegiani
Journal:  Cell Immunol       Date:  1985-04-01       Impact factor: 4.868

5.  Serum thymic hormone thymulin activity is normal in children with asthma.

Authors:  A Lurie; M Chaussain; F Raynaud; G de Montis; G Strauch; A Lockhart; J Marsac; M Dardenne
Journal:  J Allergy Clin Immunol       Date:  1989-09       Impact factor: 10.793

6.  Serum thymulin in human zinc deficiency.

Authors:  A S Prasad; S Meftah; J Abdallah; J Kaplan; G J Brewer; J F Bach; M Dardenne
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

7.  Influence of growth hormone on thymic endocrine activity in humans.

Authors:  E Mocchegiani; P Paolucci; A Balsamo; E Cacciari; N Fabris
Journal:  Horm Res       Date:  1990

Review 8.  The human thymus. A chimeric organ comprised of central and peripheral lymphoid components.

Authors:  B F Haynes; L P Hale
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

9.  Thymic dysfunction in childhood T-acute lymphoblastic leukemia: a possible linkage with a primary thymus involvement.

Authors:  R Consolini; A Legitimo; A Giorgianni; M C Putti
Journal:  Haematologica       Date:  1992 May-Jun       Impact factor: 9.941

10.  Thymic dysfunction in histiocytosis-X.

Authors:  R Consolini; P Cini; B Cei; E Bottone
Journal:  Am J Pediatr Hematol Oncol       Date:  1987
View more
  3 in total

1.  Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice.

Authors:  Rodolfo G Goya; Paula C Reggiani; Silvan M Vesenbeckh; Jean M Pléau; Yolanda E Sosa; Gloria M Cónsole; Rüdiger Schade; Peter Henklein; Mireille Dardenne
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-27       Impact factor: 4.310

Review 2.  Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

Authors:  Laurence S Harbige
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

Review 3.  Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention.

Authors:  Anna Aiello; Farzin Farzaneh; Giuseppina Candore; Calogero Caruso; Sergio Davinelli; Caterina Maria Gambino; Mattia Emanuela Ligotti; Nahid Zareian; Giulia Accardi
Journal:  Front Immunol       Date:  2019-09-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.